Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland

Status Completed

Clinical Trial Summary

The objectives of the retrospective cohort study is to describe the actual current practice of antibiotic treatment duration for bloodstream infections in critically ill patients at two tertiary hospitals (ICU Inselspital Bern and ICU CHUV Lausanne), to examine patient, pathogen and infectious syndrome factors associated with selection of shortened treatment duration, and to describe the expected time course of clinical resolution among bacteremic patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Bacteremia

Clinical Trial Details

NCT number	NCT05236283
Study type	Observational
Source	University Hospital Inselspital, Berne
Contact
Status	Completed
Phase
Start date	February 1, 2022
Completion date	March 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03894046` - Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex	Phase 3
Active, not recruiting	`NCT03354338` - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy	Phase 2
Withdrawn	`NCT02543957` - Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Completed	`NCT02210169` - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates	N/A
Completed	`NCT01410578` - The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO	N/A
Completed	`NCT00609375` - Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen	Phase 4
Terminated	`NCT00428051` - Colombia Epidemiologic Surveillance Study	N/A
Completed	`NCT00177736` - Pharmacodynamic Parameters of Two Different Doses of Cefepime	Phase 4
Terminated	`NCT00108433` - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections	Phase 3
Completed	`NCT00571259` - Prophylactic Antimicrobial Catheter Lock	Phase 4
Completed	`NCT00027248` - Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections	Phase 3
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Recruiting	`NCT05950984` - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed	`NCT03148769` - Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors
Completed	`NCT02536352` - Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being	Early Phase 1
Completed	`NCT02869191` - Blood Cultures's Profitability in Intensive Care Unit
Terminated	`NCT01734694` - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients	Phase 4
Completed	`NCT01179022` - Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions	N/A
Recruiting	`NCT00404625` - Infections Caused by ESbL-Producing Enterobacteriaceae in Italy	N/A
Completed	`NCT00398411` - Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells	Phase 3